Correlation Between Alnylam Pharmaceuticals and Jazz Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and Jazz Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and Jazz Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alnylam Pharmaceuticals and Jazz Pharmaceuticals PLC, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and Jazz Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of Jazz Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and Jazz Pharmaceuticals.

Diversification Opportunities for Alnylam Pharmaceuticals and Jazz Pharmaceuticals

-0.65

Correlation Coefficient

Alnylam Pharmaceuticals  Jazz Pharmaceuticals

Excellent diversification

The 3 months correlation between Alnylam and Jazz is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and Jazz Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jazz Pharmaceuticals PLC and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with Jazz Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jazz Pharmaceuticals PLC has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and Jazz Pharmaceuticals go up and down completely randomly.

Pair Corralation between Alnylam Pharmaceuticals and Jazz Pharmaceuticals

Given the investment horizon of 90 days Alnylam Pharmaceuticals is expected to generate 1.81 times more return on investment than Jazz Pharmaceuticals. However, Alnylam Pharmaceuticals is 1.81 times more volatile than Jazz Pharmaceuticals PLC. It trades about 0.06 of its potential returns per unit of risk. Jazz Pharmaceuticals PLC is currently generating about 0.0 per unit of risk. If you would invest  16,934  in Alnylam Pharmaceuticals on October 7, 2024 and sell it today you would earn a total of  6,494  from holding Alnylam Pharmaceuticals or generate 38.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Alnylam Pharmaceuticals  vs.  Jazz Pharmaceuticals PLC

Alnylam Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Alnylam Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Jazz Pharmaceuticals PLC

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Jazz Pharmaceuticals PLC are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Jazz Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Alnylam Pharmaceuticals and Jazz Pharmaceuticals

The main advantage of trading using opposite Alnylam Pharmaceuticals and Jazz Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, Jazz Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jazz Pharmaceuticals will offset losses from the drop in Jazz Pharmaceuticals' long position.

The idea behind Alnylam Pharmaceuticals and Jazz Pharmaceuticals PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.